Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
INGN Stock Chart & Stats
$6.21
$0.43(4.59%)
At close: 4:00 PM EST
$6.21
$0.43(4.59%)
Day’s Range― - ―
52-Week Range$5.34 - $9.13
Previous CloseN/A
Volume110.44K
Average Volume (3M)175.29K
Market Cap
$169.11M
Enterprise Value$85.05M
Total Cash (Recent Filing)$119.58M
Total Debt (Recent Filing)$17.48M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Apr 30, 2026EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding27,232,350
10 Day Avg. Volume170,224
30 Day Avg. Volume175,293
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.95
Price to Sales (P/S)0.52
P/FCF Ratio-8.46
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit0.51
Enterprise Value/Ebitda-20.72
Forecast
1Y Price Target
$13.00Price Target Upside109.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.68
Revenue Forecast (FY)$385.25M
Bulls Say, Bears Say
Bulls Say
In-house Manufacturing And Margin ImprovementAnalyst expects internally developed and manufactured Aurora masks to improve gross margins by capturing higher manufacturing value and reducing reliance on third-party suppliers.
Product Launches And AdoptionAnalyst highlights the launch of the Aurora family of CPAP masks and a new stationary oxygen concentrator, with a patient-use study showing high user satisfaction that could drive adoption in sleep and respiratory device markets.
Profitability OutlookAnalyst notes company reiterated guidance for positive adjusted EBITDA, signaling management expects to sustain profitability despite revenue pressures.
Bears Say
Broad Sales WeaknessAnalyst notes US sales, international sales, and rental revenue all came in below expectations, indicating broader demand softness across core markets.
Competitive Pressure In CPAP MarketAnalyst warns entry into the CPAP mask market will face steep competition from established players, which could limit market share gains and pressure margins.
Order Timing And Revenue VolatilityAnalyst reports timing shifts of several large customer orders that delayed revenue recognition, creating volatility in reported sales and earnings.
Inogen News
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $5.34 and its highest was $9.13 in the past 12 months.
What is Inogen’s market cap?
Inogen’s market cap is $169.11M.
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Apr 30, 2026 which is in 55 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on Feb 24, 2026. The company reported -$0.26 earnings per share for the quarter, beating the consensus estimate of -$0.357 by $0.097.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Undervalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -0.29.
How many shares outstanding does Inogen have?
Inogen has 27,232,350 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.26 in its last earnings report, beating expectations of -$0.357. Following the earnings report the stock price went up 2.911%.
Which hedge fund is a major shareholder of Inogen?
Currently, no hedge funds are holding shares in INGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (109.34% Upside)
$13.00 (109.34% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 33.2K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.40%
12-Months-Change
Fundamentals
Return on Equity
-13.27%
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
INGN Company Deck
INGN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a clear operational and strategic turnaround: mid-single-digit revenue growth, >20% unit growth, strong international momentum, return to adjusted EBITDA profitability for the year, a strengthened balance sheet with no debt and a $30M buyback authorization, and meaningful product diversification with early traction for new launches. Headwinds remain — notably U.S. sales and rental declines, gross margin compression from channel mix, timing shifts of large orders into H1 2026, and an ongoing GAAP net loss — but management provided guidance for continued adjusted EBITDA positivity, 2026 revenue growth (mid-single digits to ~6% at midpoint) and longer-term targets (high single-digit growth and ≥10% adjusted EBITDA in 3–5 years). Overall, the positive operational progress, profitability inflection, cash position and portfolio expansion outweigh the near-term channel and timing challenges.View all INGN earnings summariesINGN Stock 12 Month Forecast
Average Price Target
$13.00
▲(109.34% Upside)
Technical Analysis
Ownership Overview
2.30% Insiders
17.94% Mutual Funds
18.13% Other Institutional Investors
52.62% Public Companies and
Individual Investors